Halozyme Therapeutics shares owned by Lakeview Capital Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Lakeview Capital Partners
from 13F filings
Historical chart of Lakeview Capital Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Lakeview Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Lakeview Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $479k | 8.4k | 57.24 |
| 2024-06-30 | $372k | 9.1k | 40.68 |
| 2024-03-31 | $372k | 9.1k | 40.68 |
| 2023-12-31 | $337k | 9.1k | 36.96 |
| 2023-09-30 | $464k | 12k | 38.20 |
| 2023-06-30 | $723k | 20k | 36.07 |
| 2023-03-31 | $656k | 20k | 32.99 |
| 2022-12-31 | $991k | 19k | 51.12 |
| 2022-09-30 | $798k | 20k | 39.54 |